Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT01953575
Do patients with eosinophilic esophagitis have baseline increased esophageal mucosal impedance?
And will treatment that reverses esophageal eosinophilia in patients, correct abnormalities in mucosal impedance?
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A tiny tube will be placed through the endoscope into the esophagus. 5 cm above where the stomach and esophagus meet for 5 seconds. At 10 cm above where the stomach and esophagus meet the catheter will be placed for 5 seconds. And at 20 cm above where the stomach and esophagus meet the catheter will be placed for 5 seconds.
Other names: ph impedance, ph monitor
Esophagogastroduodenoscopy, also called by various other names, is a diagnostic endoscopic procedure that visualizes the upper part of the gastrointestinal tract down to the duodenum.
Other names: Esophagogastroduodenoscopy (EGD)
Time frame: baseline to one year
An endoscopically placed probe measured electrical impedance of the esophageal lining by direct mucosal contact. Impedance measurements of the esophageal mucosa were expressed in ohms as the ratio of voltage to current Impedance measurements were obtained at 2, 5, 10, and 15 cm above the gastroesophageal junction.
Mayo Clinic
Other
Mucosal Impedance in Eosinophilic Esophagitis and the Effect of Treatment
Acronym: EoE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06501274
Digestive System Diseases, Eosinophilia
Stevenage, Hertfordshire, United Kingdom
View Trial DetailsNCT01988285
Digestive System Diseases, Eosinophilia
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07093008
Digestive System Diseases, Eosinophilia
Madison, Wisconsin, United States
View Trial DetailsNCT05774184
Digestive System Diseases, Eosinophilia
Birmingham, Alabama, United States
View Trial Details